(For a live blog on the U.S. stock market, clickLIVE/ or type LIVE/ in a news window.) * Gilead analysis shows remdesivir reduced coronavirus death risk * Carnival rises on plan to resume trips in phases * S&P 500 financial index rises 3.5% * Indexes: Dow up 1.4%, S&P 500 up 1.1%, Nasdaq up 0.7% (Updates close with VIX) By Caroline Valetkevitch July 10 (Reuters) - U.S. stocks rose on Friday as a positive analysis on Gilead Sciences Inc's antiviral drug to treat COVID-19 helped to soothe investor worries over a record rise in coronavirus cases in the United States, and as financial shares surged. The Nasdaq posted its sixth record closing high in seven days, but the index underperformed both the Dow and S&P 500, in a reversal of the recent trend. The S&P 500 financials index.SPSY rose 3.5%, leading sector gains and giving the S&P 500 its biggest boost. Bank of America CorpBAC.N shares increased 5.5%, Citigroup IncC.N jumped 6.5% and JPMorgan Chase & CoJPM.N climbed 5.5% ahead of their financial results next week, which will mark the onset of the second-quarter earnings season. Rob Haworth, senior investment strategist at U.S. Bank Wealth Management in Seattle, said there was a rotation "from winners into laggards" in Friday's trading, with the earnings period around the corner. The United States registered the largest single-day increase in new COVID-19 infections globally for the second day in a row on Thursday, forcing Americans to take new precautions. Several states have already backpedaled on reopening plans.urn:newsml:reuters.com:*:nL1N2EG13N Gilead'sGILD.O remdesivir significantly improved clinical recovery and reduced the risk of death in COVID-19 patients, additional data from a late-stage study showed. The drugmaker's shares climbed 2.2% as it said the finding required confirmation in clinical trials.urn:newsml:reuters.com:*:nL4N2EH2TR "That kind of dampened some of the concern that's been building over the past few days around the increased virus cases in the southern states," said Charlie Ripley, senior investment strategist for Allianz Investment Management in Minneapolis. The Dow Jones Industrial Average.DJI rose 369.21 points, or 1.44%, to 26,075.3, the S&P 500.SPX gained 32.99 points, or 1.05%, to 3,185.04 and the Nasdaq Composite.IXIC added 69.69 points, or 0.66%, to 10,617.44. For the week, the Dow rose 1%, the S&P 500 gained 1.8% and the Nasdaq jumped 4%. The Cboe Volatility index.VIX ended down on the day and fell 0.39 points for the week. Overall profits for S&P 500 companies are expected to have fallen more than 40% in the second quarter, which would be the biggest quarterly profit decline since the financial crisis, according to IBES data from Refinitiv. The first coronavirus cases in the United States were identified in January and within weeks much of the economy was shut down to slow the spread, throwing millions of Americans into unemployment. Companies across a range of industries have been dealing with the aftermath ever since.urn:newsml:reuters.com:*:nL1N2EG1J9 The S&P 500 is up more than 40% from its March 23 bottom, thanks in part to economic data that has pointed to a revival in business activity in June. Carnival CorpCCL.N jumped 10.8% after the cruise line operator said it was planning to resume operations in a phased manner and would operate with a smaller fleet on its return.urn:newsml:reuters.com:*:nL4N2EH2XM Netflix IncNFLX.O rose 8.1% after Goldman Sachs hiked its price target on the video streaming service's shares. Advancing issues outnumbered declining ones on the NYSE by a 2.87-to-1 ratio; on Nasdaq, a 1.62-to-1 ratio favored advancers. The S&P 500 posted 19 new 52-week highs and no new lows; the Nasdaq Composite recorded 85 new highs and 17 new lows. Volume on U.S. exchanges was 9.57 billion shares, compared with the 11.93 billion average for the full session over the last 20 trading days. (Additional reporting by Medha Singh and C Nivedita in Bengaluru; Editing by Marguerita Choy and Maju Samuel) ((caroline.valetkevitch@thomsonreuters.com; +1 646 223 6393; Reuters Messaging: caroline.valetkevitch.thomsonreuters.com@reuters.net))

Warning: This material has been prepared by a third party company, Reuters, which is independent of Davy. Davy has not reviewed the material and accepts no responsibility for errors or omissions, or for the information or opinions contained therein. It does not constitute investment advice.
Warning: This content may be provided by regulated and unregulated entities and is not created, reviewed or endorsed by Davy. It is provided for general information purposes only and does not constitute a recommendation or solicitation to purchase or sell any security or make any other type of investment or investment decision. Importantly, it does not constitute investment advice, as it does not contemplate the personal circumstances of any particular person or group of persons. Neither Davy nor the providers of the Third Party Content will be liable for any investment decision made based on the reliance on or use of such data, or any liability that may arise due to delays or interruptions in the delivery of the Third Party Content for any reason.
Latest News

ReutersFOREX-Dollar reaches one-month highs as markets eye Biden's FX policy
ReutersPRECIOUS-Gold recovers as U.S. stimulus hopes buoy appeal
ReutersUPDATE 6-Oil falls on coronavirus fears, strong dollar
ReutersPRECIOUS-Gold edges higher off 1-1/2 month low despite buoyant dollar
ReutersFOREX-Dollar at 1-month highs as markets eye Biden's FX policy; euro slips
ReutersUPDATE 1-European stocks slip as Carrefour abandons takeover talks
ReutersUPDATE 1-FTSE 100 dips as oil, travel stocks weigh
ReutersFOREX-Dollar stands tall despite strong Chinese data; euro struggles
ReutersEuropean stocks slip as Carrefour abandons takeover talks
ReutersFTSE 100 slips as oil, travel stocks weigh